In Vitro-ln Vivo Correlation for Modified-Release Formulations
- 1 February 1993
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 82 (2), 132-137
- https://doi.org/10.1002/jps.2600820204
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Relevance of pH Dependency on in Vitro Release of Bromocriptine from a Modified-Release FormulationJournal of Pharmaceutical Sciences, 1991
- Comparison of methods to calculate cyclosporine a bioavailability from consecutive oral and intravenous dosesJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulationEuropean Journal of Clinical Pharmacology, 1988
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986
- In vitro ? In vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical exampleEuropean Journal of Clinical Pharmacology, 1985
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Treatment of Parkinson's Disease with BromocriptineNew England Journal of Medicine, 1976
- Bromocriptine treatment of acromegaly.BMJ, 1975
- Pharmacokinetic criteria for the evaluation of retard formulationsEuropean Journal of Clinical Pharmacology, 1974
- Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind StudyBMJ, 1972